🔎 Trials Near Me

Početna › Debljina › Texas › Houston

Kliničke studije za Debljina u gradu Houston, TX

43 studija za Debljina traži sudionike na lokacijama u gradu Houston i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

U tijeku regrutacijaFaza 2
  • Juno Research /ID# 282413, Houston
  • PlanIt Research /ID# 282204, Houston
  • JCCT - Juno Bellaire /ID# 282263, Bellaire · 7 mi udaljenosti
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

U tijeku regrutacijaFaza 2
  • Cardiovascular Specialists of Willowbrook, Houston
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07783802

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

U tijeku regrutacijaFaza 3
  • PlanIt Research, PLLC, Houston
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

U tijeku regrutacijaFaza 3
  • DM Clinical, Houston
Od 8 do 18 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

U tijeku regrutacijaFaza 3
  • Houston Research Institute, Houston
  • The Endocrine Center, Houston
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07668414

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

U tijeku regrutacijaFaza 3
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07595549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

U tijeku regrutacijaFaza 3
  • McGovern Medical School, Houston
  • Texas Childrens Hospital, Houston
  • Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
  • i još 1
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • Juno Research, Houston
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

U tijeku regrutacijaFaza 3
  • Juno Research, Houston
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

U tijeku regrutacijaFaza 3
  • Research Site, Houston
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

U tijeku regrutacijaFaza 3
  • Biopharma Informatic, LLC, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
  • PlanIt Research, PLLC, Houston
  • i još 2
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • The University of Texas Health Science Center at Houston, Bellaire · 7 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

U tijeku regrutacijaFaza 3
  • Care Access - Houston, Houston
  • JCCT - Juno Bellaire Site, Bellaire · 7 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • PlanIt Research, PLLC, Houston
Od 18 do 75 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

U tijeku regrutacijaFaza 2Zdravi dobrovoljci dobrodošli
  • The University of Texas Health Science Center at Houston, Houston
Od 18 do 75 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • AURORA-2 Clinical Site, Houston
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

U tijeku regrutacijaFaza 3
  • East Texas Cardiology PA, Houston
  • Biopharma Informatic, Houston
  • Orion Medical, Houston
  • i još 3
Od 18 do 99 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • HRI ? Medical Center, LLC, Houston
  • Juno Research, LLC, Houston
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

U tijeku regrutacijaFaza 2
  • Juno Research, Houston
Od 18 do 75 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • Elevate Clinical, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, LLC, Bellaire · 7 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

U tijeku regrutacijaFaza 3Zdravi dobrovoljci dobrodošli
  • ACCOMPLISH-2 Research Site, Houston
  • ACCOMPLISH-2 Research Site, Houston
Od 18 do 79 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • PlanIt Research, PLLC, Houston
Od 18 do 75 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

U tijeku regrutacijaFaza 2
  • Biopharma Informatic, LLC, Houston
  • PlanIt Research, PLLC, Houston
  • Research Physicians Network, LLC, Houston
Od 18 do 75 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

U tijeku regrutacijaFaza 4
  • Center for Clinical Studies, Houston
  • Bellaire Dermatology Associates, Bellaire · 7 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT06857942

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

U tijeku regrutacijaFaza 3
  • JCCT- Juno Northwest Houston, Houston
  • Biopharma Informatic, LLC, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi udaljenosti
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

U tijeku regrutacijaFaza 3
  • Kailera Clinical Site, Bellaire · 7 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

U tijeku regrutacijaFaza 3
  • JCCT- Juno Northwest Houston, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi udaljenosti
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

U tijeku regrutacijaFaza 3
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network, LLC, Houston
Od 18 do 99 godina · Oba spola · Ažurirano 27. kol 2026. · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

U tijeku regrutacijaFaza 3
  • Research Site, Houston
Od 18 godina i više · Oba spola · Ažurirano 25. kol 2026. · NCT07784725

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

U tijeku regrutacijaFaza 2
  • Baylor Texas Children's Hospital, Houston
Od 7 do 25 godina · Oba spola · Ažurirano 19. kol 2026. · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

U tijeku regrutacijaFaza 3
  • East Texas Cardiology PA, Houston
  • Victorium Clinical Research, Houston
  • Main Heart Clinic, Houston
  • i još 1
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

U tijeku regrutacijaFaza 3
  • ACCOMPLISH-1 Research Site, Houston
  • ACCOMPLISH-1 Research Site, Houston
Od 18 do 79 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07654361

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

U tijeku regrutacijaZdravi dobrovoljci dobrodošli
  • Children's Nutrition Research Center, Houston
Od 12 do 18 godina · Oba spola · Ažurirano 7. srp 2026. · NCT06959901

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

U tijeku regrutacijaZdravi dobrovoljci dobrodošliNavodi plaćanje za sudionike
  • USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
Od 14 do 16 godina · Oba spola · Ažurirano 7. srp 2026. · NCT06943001

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
  • Lilli Health, Houston
Od 18 godina i više · Oba spola · Ažurirano 1. svi 2026. · NCT05950282

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

U tijeku regrutacija
  • M D Anderson Cancer Center, Houston
Od 18 godina i više · Žene · Ažurirano 21. tra 2026. · NCT04003038

Incretin Microdosing for Cardiometabolic Health in People With HIV

U tijeku regrutacijaFaza 2
  • The University of Texas Health Science Center at Houston, Houston
Od 18 godina i više · Oba spola · Ažurirano 18. velj 2026. · NCT07325500

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

U tijeku regrutacijaFaza 2
  • Baylor College of Medicine, Houston
Od 18 godina i više · Oba spola · Ažurirano 16. sij 2026. · NCT06273072

RESET System Pivotal Trial (Rev F)

U tijeku regrutacija
  • Baylor College of Medicine, Houston
Od 22 do 65 godina · Oba spola · Ažurirano 18. srp 2024. · NCT04101669

Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity

U tijeku regrutacija
  • Houston Methodist Hospital, Houston
Od 18 godina i više · Oba spola · Ažurirano 1. tra 2024. · NCT06339320

Studije za Debljina u drugim gradovima

Ostale studije u gradu Houston

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.